Clinical Trials Logo

Taste Disorder, Secondary, Sweet clinical trials

View clinical trials related to Taste Disorder, Secondary, Sweet.

Filter by:
  • None
  • Page 1

NCT ID: NCT05104424 Not yet recruiting - Taste Disorders Clinical Trials

The Study of Quadruple Therapy Intranasal Insulin, Zinc, Gabapentin, Ice Cube Stimulation for Post COVID-19 Smell and Taste Dysfunctions

COVID-19
Start date: December 26, 2021
Phase: Phase 1
Study type: Interventional

post covid-19 smell and taste dysfunction are common globally and affect the quality of life and also have phycological impact and anxiety, also affect on economy as the patients not able to do cooking or buy prepared foods and not eaten, also not able to enter the cooking room and prepare foods for themselves, also the risk of loss of smell the fire accidents because anosmia, many forms of smell dysfunction like anosmia ,hyposmia, and dysosmia ,Phantosmia , parosmia may occurred, the same taste disorders may has many forms like Dysgeusia, phantom taste perception, hypogeusia with dysgeusia. until now no definite treatments for post covid-19 smell and taste disorders , this study is novel study as quadruple therapy Intranasal Insulin, Zinc, Gabapentin, Ice Cube Stimulation may suspect having promising results

NCT ID: NCT01302574 Completed - Clinical trials for Taste Disorder, Secondary, Sweet

Role of the Gut Sweet Taste Receptor in the Secretion of Satiation Peptides

Start date: January 2010
Phase: Phase 1
Study type: Interventional

The purpose of this study is to determine the functional significance of sweet taste receptors in the secretion of gastrointestinal (GI) satiation peptides by using a specific sweet taste receptor antagonist to block sweet taste perception in the gastrointestinal tract.